#FutureReadyHealthcare
Indegene
Search Icon
Indegene Exceeds Co-promotion forecasts for 3 Ophthalmology Brands ​
Home
What we think
Case studies

Indegene Exceeds Co-promotion forecasts for 3 Ophthalmology Brands ​

The Customer

A global pharmaceutical company with a vision to explore new ways to improve and extend people’s lives had 7 brands in their ophthalmology/PCP portfolio that were in mature stages. The client was looking for a partner to take over sales and marketing.

Challenges

  • With new drugs in the pipeline, the client reprioritized its salesforce in preparation for the new launches​

    Stabilize revenue decline and improve market share​

    Establish a proof of concept for 3 brands within 6 months​

The Solution

  • Indegene segmented HCP targets from its IP along with clients’ data. HCPs were first segmented based on the likelihood of writing Rx and further segmented based on digital affinity

    Indegene’s experienced medical writers and designers created compelling campaigns for different target segments across multiple channels using insights from Indegene’s Next HCP Journey Optimization​

    Deployed an omnichannel strategy using Rep Equivalence Model to implement an optimized channel mix and drove product awareness and engagement​

Outcomes

  • Indegene delivered 3.5 million+ touchpoints, which resulted in $4.2 million incremental revenue in 6 months that surpassed forecasts

    Revenue by brand​

    Brand 1 (PCP/seasonal): $833,172​

    Brand 2 (PCP/seasonal): $1,385,616​

    Brand 3 (ophthalmology): $2,044,698 ​

    Worked as a self-sustaining partner to limit client burden and infrastructure needs​

    Extended the pilot program to include the entire portfolio​

3.5 million

Touchpoints

4.2 million

Incremental sales

4

New brands into the portfolio

Powered by Onetrust